| Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease SAB Paisán-Ruíz C1, Jain S, Evans EW, Gilks WP, Simón J, van der Brug M ... Neuron 44 (4), 595-600, 2004 | 2757 | 2004 |
| Early treatment of Parkinson’s disease with cabergoline delays the onset of motor complications: results of a double-blind levodopa controlled trial UK Rinne, F Bracco, C Chouza, E Dupont, O Gershanik, JF Marti Masso, ... Drugs 55, 23-30, 1998 | 449 | 1998 |
| Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy JM Morante-Redolat, A Gorostidi-Pagola, S Piquer-Sirerol, A Sáenz, ... Human molecular genetics 11 (9), 1119-1128, 2002 | 379 | 2002 |
| Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease LV Kalia, AE Lang, LN Hazrati, S Fujioka, ZK Wszolek, DW Dickson, ... JAMA neurology 72 (1), 100-105, 2015 | 323 | 2015 |
| Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases. F Gómez-Aranda, F Canadillas, JF Martí-Massó, E Díez-Tejedor, ... Brain: a journal of neurology 120 (7), 1105-1113, 1997 | 218 | 1997 |
| Limb-girdle muscular dystrophy in Guipúzcoa (Basque Country, Spain). M Urtasun, A Saenz, C Roudaut, JJ Poza, JA Urtizberea, AM Cobo, ... Brain: a journal of neurology 121 (9), 1735-1747, 1998 | 214 | 1998 |
| Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics SS Junger, BJ Stern, SR Levine, E Sipos, JF Marti-Masso Neurology 43 (2), 333-333, 1993 | 188 | 1993 |
| LGMD2A: genotype–phenotype correlations based on a large mutational survey on the calpain 3 gene A Saenz, F Leturcq, AM Cobo, JJ Poza, X Ferrer, D Otaegui, P Camano, ... Brain 128 (4), 732-742, 2005 | 179 | 2005 |
| The long-acting dopamine receptor agonist cabergoline in early Parkinson’s disease: final results of a 5-year, double-blind, levodopa-controlled study F Bracco, A Battaglia, C Chouza, E Dupont, O Gershanik, JFM Masso, ... CNS drugs 18, 733-746, 2004 | 177 | 2004 |
| Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa UK Rinne, F Bracco, C Chouza, E Dupont, O Gershanik, JFM Masso, ... Neurology 48 (2), 363-368, 1997 | 177 | 1997 |
| Autosomal dominant lateral temporal epilepsy: clinical and genetic study of a large Basque pedigree linked to chromosome 10q JJ Poza, A Saenz, A Martinez‐Gil, N Cheron, AM Cobo, M Urtasun, ... Annals of Neurology: Official Journal of the American Neurological …, 1999 | 166 | 1999 |
| Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers KB Fraser, MS Moehle, RN Alcalay, AB West, LRRK2 Cohort Consortium, ... Neurology 86 (11), 994-999, 2016 | 135 | 2016 |
| Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1 A Sistiaga, I Urreta, M Jodar, AM Cobo, J Emparanza, D Otaegui, JJ Poza, ... Psychological medicine 40 (3), 487-495, 2010 | 129 | 2010 |
| Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis I Agalliu, M San Luciano, A Mirelman, N Giladi, B Waro, J Aasly, ... JAMA neurology 72 (1), 58-65, 2015 | 121 | 2015 |
| Phenotypic variability in familial prion diseases due to the D178N mutation JJ Zarranz, A Digon, B Atares, AB Rodriguez-Martinez, A Arce, N Carrera, ... Journal of Neurology, Neurosurgery & Psychiatry 76 (11), 1491-1496, 2005 | 119 | 2005 |
| Pharmacological options for the treatment of Tourette’s disorder FJ Jiménez-Jiménez, PJ García-Ruiz Drugs 61, 2207-2220, 2001 | 110 | 2001 |
| Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques J Simón‐Sánchez, JF Martí‐Massó, JV Sánchez‐Mut, C Paisán‐Ruiz, ... Movement disorders: official journal of the Movement Disorder Society 21 (11 …, 2006 | 109 | 2006 |
| Prevalence of Parkinson’s disease and other types of Parkinsonism: a door-to-door survey in Bidasoa, Spain A Bergareche, E De La Puente, A López de Munain, C Sarasqueta, ... Journal of neurology 251, 340-345, 2004 | 108 | 2004 |
| Cinnarizine‐induced parkinsonism: ten years later JF Martí‐Massó, JJ Poza Movement disorders 13 (3), 453-456, 1998 | 106 | 1998 |
| Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation C Manzoni, A Mamais, S Dihanich, P McGoldrick, MJ Devine, J Zerle, ... Biochemical and biophysical research communications 441 (4), 862-866, 2013 | 101 | 2013 |
Adolfo Lopez de MunainJefe del Servicio de Neurología - Hospital Universitario Donostia / Director Área de NeurocienciasVerified email at osakidetza.eus
